No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
NKTX Nkarta
- 6.645
- -0.305-4.39%
Trading May 23 12:17 ET
468.26MMarket Cap-2827P/E (TTM)
6.940High6.550Low94.57KVolume6.940Open6.950Pre Close631.06KTurnover0.30%Turnover RatioLossP/E (Static)70.47MShares16.24052wk High0.99P/B212.08MFloat Cap1.28052wk Low--Dividend TTM31.92MShs Float79.160Historical High--Div YieldTTM5.61%Amplitude1.280Historical Low6.673Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Analysts Have Conflicting Sentiments on These Healthcare Companies: Deciphera Pharmaceuticals (DCPH), Atara Biotherapeutics (ATRA) and Nkarta (NKTX)
EnGene Holdings: Nkarta's Paul Hastings and Forbion's Wouter Joustra Elected to Bd >ENGN
EnGene Holdings: Nkarta's Paul Hastings and Forbion's Wouter Joustra Elected to Bd >ENGN
Nkarta Price Target Raised to $23.00/Share From $22.00 by HC Wainwright & Co.
Nkarta Price Target Raised to $23.00/Share From $22.00 by HC Wainwright & Co.
Nkarta Is Maintained at Buy by Needham
Nkarta Is Maintained at Buy by Needham
Express News | Needham Maintains Buy on Nkarta, Lowers Price Target to $13
Nkarta (NASDAQ:NKTX) Is In A Good Position To Deliver On Growth Plans
Comments
» Holdings: 75
» Holdings in Top 20: 70.21%
» Qtr over Qtr Change**: +21.81%
Top Holdings:
$Ascendis Pharma A/S(ASND.US$
$Vaxcyte(PCVX.US$
$Legend Biotech(LEGN.US$
$Janux Therapeutics(JANX.US$
$Aerovate(AVTE.US$
$Rhythm Pharmaceuticals(RYTM.US$
$Evolent Health(EVH.US$
$NewAmsterdam Pharma(NAMS.US$
$RxSight(RXST.US$
$TYRA BIOSCIENCES, INC.(TYRA.US$
$Edgewise Therapeutics(EWTX.US$
$4D Molecular Therapeutics(FDMT.US$
$Biogen(BIIB.US$
$PepGen(PEPG.US$
...
» Holdings in Top 20: 70.21%
» Qtr over Qtr Change**: +21.81%
Top Holdings:
$Ascendis Pharma A/S(ASND.US$
$Vaxcyte(PCVX.US$
$Legend Biotech(LEGN.US$
$Janux Therapeutics(JANX.US$
$Aerovate(AVTE.US$
$Rhythm Pharmaceuticals(RYTM.US$
$Evolent Health(EVH.US$
$NewAmsterdam Pharma(NAMS.US$
$RxSight(RXST.US$
$TYRA BIOSCIENCES, INC.(TYRA.US$
$Edgewise Therapeutics(EWTX.US$
$4D Molecular Therapeutics(FDMT.US$
$Biogen(BIIB.US$
$PepGen(PEPG.US$
...
5
$Nkarta(NKTX.US$ jesus have some mercy
$Nkarta(NKTX.US$ Nkarta Prices Its Underwritten Offering Of 21M Shares At $10.00/Share And Pre-funded Warrants To Purchase 3M Shares At $9.9999/Warrant, With Gross Proceeds Of Approximately $240.1M
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg